Free Trial

PureTech Health (LON:PRTC) Stock Price Up 9.1% - Still a Buy?

PureTech Health logo with Medical background

Key Points

  • PureTech Health plc shares increased by 9.1%, reaching a trading price of GBX 116.04 ($1.57), with approximately 866,820 shares traded, demonstrating a significant rise in market activity.
  • The company has a market capitalization of £283.50 million and notable financial ratios, including a debt-to-equity ratio of 45.82 and a high P/E ratio of 690.00.
  • Insider Bharatt Chowrira purchased 167,739 shares at an average cost of GBX 1 per share, indicating insider confidence in the company's prospects.
  • MarketBeat previews the top five stocks to own by October 1st.

PureTech Health plc (LON:PRTC - Get Free Report) rose 9.1% during trading on Friday . The company traded as high as GBX 116.80 ($1.57) and last traded at GBX 116.04 ($1.56). Approximately 866,820 shares traded hands during trading, an increase of 18% from the average daily volume of 736,782 shares. The stock had previously closed at GBX 106.40 ($1.43).

PureTech Health Price Performance

The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 45.82. The firm has a market cap of £293.65 million, a PE ratio of 714.71 and a beta of 1.02. The business has a fifty day moving average of GBX 129.46 and a 200-day moving average of GBX 129.76.

Insider Transactions at PureTech Health

In related news, insider Bharatt Chowrira acquired 167,739 shares of the stock in a transaction on Thursday, July 3rd. The stock was acquired at an average price of GBX 1 per share, for a total transaction of £1,677.39. Insiders own 13.13% of the company's stock.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

See Also

Should You Invest $1,000 in PureTech Health Right Now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.